Letter regarding "Feasibility of additional radiotherapy in patients with advanced hepatocellular carcinoma treated with atezolizumab plus bevacizumab". | J Liver Cancer;23(2): 402-404, 2023 Sep. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search EVID@Easy

Letter regarding "Feasibility of additional radiotherapy in patients with advanced hepatocellular carcinoma treated with atezolizumab plus bevacizumab".

Bae, Sun Hyun; Park, Hee Chul.

Affiliation

Bae SH; Department of Radiation Oncology, Soonchunhyang University College of Medicine, Bucheon, Korea.
Park HC; Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

J Liver Cancer ; 23(2): 402-404, 2023 Sep.

Article in En | MEDLINE | ID: mdl-37680020

Key words

Atezolizumab; Bevacizumab; Carcinoma, hepatocellular; Radiotherapy

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: J Liver Cancer Year: 2023 Document type: Article Country of publication: Korea (South)

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: J Liver Cancer Year: 2023 Document type: Article Country of publication: Korea (South)